Advanced Oncotherapy PLC (AVO) Insider Buys £104,000 in Stock
Advanced Oncotherapy PLC (LON:AVO) insider Steve Myers OBE bought 400,000 shares of the firm’s stock in a transaction that occurred on Monday, May 15th. The stock was bought at an average cost of GBX 26 ($0.34) per share, for a total transaction of £104,000 ($134,245.51).
Shares of Advanced Oncotherapy PLC (LON:AVO) opened at 26.50 on Wednesday. The firm’s 50-day moving average price is GBX 27.48 and its 200-day moving average price is GBX 57.12. The company’s market capitalization is GBX 15.03 million. Advanced Oncotherapy PLC has a 12-month low of GBX 20.18 and a 12-month high of GBX 209.88.
Separately, Beaufort Securities reaffirmed a “speculative buy” rating on shares of Advanced Oncotherapy PLC in a report on Tuesday, January 24th.
Advanced Oncotherapy PLC Company Profile
Advanced Oncotherapy Plc is focused on providing radiotherapy systems for cancer treatment through the use of a proton therapy technology. The Company is engaged in development and then building of the Linac Image Guided Hadron Technology (LIGHT) proton beam cancer therapy device and management of healthcare related property.
Receive News & Ratings for Advanced Oncotherapy PLC Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Advanced Oncotherapy PLC and related companies with MarketBeat.com's FREE daily email newsletter.